Pompe disease is a rare neuromuscular disorder that varies in its age of onset, symptoms, and rate of progression

BrandX® is a long-acting human insulin analog indicated to improve glycemic control in adults with diabetes mellitus. BrandX® should be administered subcutaneously once a day at the same time every day. Important Limitations of Use: BrandX® is not recommended for treating diabetic ketoacidosis. Use intravenous, short-acting insulin instead.

YOU ARE NOW LEAVING THE

WEBSITE

Click CANCEL to return to this site. Click CONTINUE to leave.

You are about to leave sanofi site for U.S.

Sanofi US does not review the information
contained on this website and/or database
for content, accuracy or completeness. Use
of and access to this information is subject to
the terms, limitations and conditions set by the
website and/or database producer.